ERLOTERO 150MG TABLET

Form: Tablets

Pack Size: 30 TABLETS

Marketed by: HETERO HEALTHCARE LTD (ONCOLOGY DIV)

MRP: ₹1396.00

HETERO HEALTHCARE LTD (ONCOLOGY DIV): Erlotero 150MG Tablet, 30 tablets, salt erlotinib 150mg. NPPA has revised its MRP from Rs 4,504.50 to Rs 1,396 (69% lower) with effect from 09-11-2026; trade rate Rs 1,063.62. Group: EGFR tyrosine kinase inhibitor (targeted therapy). Same salt is also supplied by Cipla, Natco, Neon, Reliance Life Sciences. Handling/counselling: take on an empty stomach; smoking reduces its effect. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.